Posts Tagged ‘drugs’
FDA Finally Admits That Drugs for Crohn’s Disease and Arthritis May Promote Cancer
The FDA has ordered makers of drugs for a variety of inflammatory diseases to add a “black box warning” about an increased risk of cancer in children and adolescents.
Researchers Turn Mosquitoes Into Flying Vaccinators
Scientists have dreamed up various ways to tinker with insects’ DNA to fight disease. One option is to create strains of mosquitoes that are resistant to infections with parasites or viruses, or that are unable to pass the pathogens on to humans.
Overlooked 150 Year Old Household Cleaner a Remedy for Swine Flu?
In today’s modern world of medicine the FDA just will not let companies that sell products make medical claims about them unless they have been tested at great expense and approved as a drug.
Antibiotic Overuse Could Threaten Medicine
Overuse of antibiotics in Europe is building widespread resistance and threatening to halt vital medical treatments such as hip replacements, intensive care for premature babies and cancer therapies, health experts say.
8 Drugs Doctors Will Not Take
Of course, plenty of M.D.’s do know which prescription and over-the-counter drugs are duds, dangers, or both. So we asked them, “Which medications would you skip?”
3 Must Know Signs Someone Has Suffered A Stroke
Written By: Dr. Wegmann Recently I preformed an exam on a patient that had no deep tendon reflexes on the right side of her body. This indicates that the patient had suffered a stroke at some point in their life. Fortunately there were no other residual side effects.
Chiropractic vs. Swine Flu
With today’s headlines dominated by the swine flu we need to learn more in order to protect ourselves and our families. The 1918 Flu killed an estimated 40 million people world wide. I pray this outbreak does not reach that proportion. I cannot comprehend the psychological impact of death on this scale in society today. Here’s a little history on the swine flu.
Doctors Increasingly Close Doors to Drug Reps
Pharmaceutical companies — battered by a sluggish drug pipeline, the looming loss of blockbuster patented drugs, an economy in recession and scrutiny of their relationships with physicians — are re-examining the value of sending drug reps into doctors’ offices. Detailers are struggling to grab a shrinking slice of physicians’ valuable time and attention while adjusting to new drug industry rules banning freebies such as pens and notepads.
